Efficacy of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders
Efficacy of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders
To assess the effect of a probiotic product, when co-administered with antibiotics, on
 gastrointestinal symptoms following antibiotic treatment in children.
Inclusion Criteria:

 -  Children at the age of 1-11 years that have been prescribed antibiotic treatment.

 -  Problems with loose stools during earlier antibiotic treatments.

 -  Children whose parents or legal caregivers have signed the informed consent to
 participate in the study.

 Exclusion Criteria:

 -  Chronic intestinal disease, immunodeficiency or immunosuppressive treatment.

 -  Chronic or acute diarrheal disease.

 -  Use of laxatives the week before inclusion in the study.

 -  Antibiotic treatment for the last four weeks before inclusion in the study.

 -  Intake of probiotic products for the last two weeks before inclusion in the study.

 -  Known hypersensitivity to any of the ingredients in the probiotic product or the
 placebo (potato starch ± bacterial culture that may contain traces of soy).

 -  Patient requiring hospitalisation.